B6.129P2-Sp1tm1Phi/Cnrm

Status

Available to order

EMMA IDEM:02430
International strain nameB6.129P2-Sp1tm1Phi/Cnrm
Alternative nameSp1 knockout
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolSp1tm1Phi,
Gene/Transgene symbolSp1

Information from provider

ProviderSjaak Philipsen
Provider affiliationGenetics, Erasmus MC
Genetic informationA 129 mouse cosmid genomic DNA library was screened with a probe spanning nucleotides 1820-2103 of pSp1-778c corresponding to the C-terminal end of Sp1. Six overlapping cosmids were isolated containing two exons encoding the zinc fingers and the C-terminus of Sp1. The neomycin targeting vector (pBSp1/Neo) is a promoterless construct containing 2 kb 5' and 3.7 kb 3' regions of homology to the Sp1 gene in pBS II KS. The beta-geo cassette containing a splice acceptor and the picornaviral IRES replaces the 2 kb NcoI fragment with the two exons encoding the zinc fingers and C−terminus of Sp1.
Phenotypic informationSp1-/- embryos survive until day 9.5 (E9.5) of gestation. They are severely retarded in growth and show a broad range of phenotypic abnormalities. Sp1-/- ES cells contribute extensively to every tissue of chimeras until E9.5 but fail to contribute after early embryonic development.
Breeding historyThe line was backcrossed to C57BL/6 for more than 6 generations.
References
  • Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation.;Marin M, Karis A, Visser P, Grosveld F, Philipsen S, ;1997;Cell;89;619-28; 9160753
  • Sp1/Sp3 compound heterozygous mice are not viable: impaired erythropoiesis and severe placental defects.;Krüger Imme, Vollmer Marion, Simmons David G, Elsässer Hans-Peter, Philipsen Sjaak, Suske Guntram, ;2007;Developmental dynamics : an official publication of the American Association of Anatomists;236;2235-44; 17584888

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

MGI phenotypes (allele matching)
  • decreased body size / MGI
  • anophthalmia / MGI
  • decreased erythroid progenitor cell number / MGI
  • decreased embryo size / MGI
  • abnormal embryonic tissue morphology / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI

Literature references

  • Transcription factor Sp1 is essential for early embryonic development but dispensable for cell growth and differentiation.;Marin M, Karis A, Visser P, Grosveld F, Philipsen S, ;1997;Cell;89;619-28; 9160753
  • Sp1/Sp3 compound heterozygous mice are not viable: impaired erythropoiesis and severe placental defects.;Krüger Imme, Vollmer Marion, Simmons David G, Elsässer Hans-Peter, Philipsen Sjaak, Suske Guntram, ;2007;Developmental dynamics : an official publication of the American Association of Anatomists;236;2235-44; 17584888

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).